Market overview

Market expert Sunil Subramaniam in an interview to ET Now said that IT and Pharma sectors are underperforming due to uncertainty around tariffs. Foreign institutional investors (FII) have been selling, while domestic fund managers are holding large cash reserves. Sunil Subramaniam points out that the proposed 10% tariff by Trump could hurt pharma earnings, leading to reduced buying in these sectors.